TSHA EBITDA Margin

Taysha Gene Therapies Inc · EBITDA Margin

TSHA logo

TSHA EBITDA Margin

Latest reported-2714.33%
TSHA EBITDA Margin (0.00% → -2714.33%)
High-resolution chart · PNG

TSHA ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Taysha Gene Therapies Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-1,102.906%
-1,055.4542%
-680.8427%
-6,436.6107%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.